Loader

Pathways

PathWhiz ID Pathway Meta Data

PW353410

Pw353410 View Pathway
metabolic

Trehalose Degradation I (Low Osmolarity)

Trabulsiella guamensis ATCC 49490
In E.coli, trehalose can be only synthesized with high osmolarity, and if the osmolarity is low, then the source of trehalose can be only obtained from external via transportation with trehalose PTS permease. However, sugar can be degraded with both low or high osmolarity in E.coli. Glucokinase can phosphorylate free gluocose into glucose-6-phosphate and both glucose-6-phosphate moieties enter glycolysis.

PW353388

Pw353388 View Pathway
metabolic

Trehalose Degradation I (Low Osmolarity)

Citrobacter youngae ATCC 29220
In E.coli, trehalose can be only synthesized with high osmolarity, and if the osmolarity is low, then the source of trehalose can be only obtained from external via transportation with trehalose PTS permease. However, sugar can be degraded with both low or high osmolarity in E.coli. Glucokinase can phosphorylate free gluocose into glucose-6-phosphate and both glucose-6-phosphate moieties enter glycolysis.

PW353465

Pw353465 View Pathway
metabolic

Trehalose Degradation I (Low Osmolarity)

Providencia alcalifaciens DSM 30120
In E.coli, trehalose can be only synthesized with high osmolarity, and if the osmolarity is low, then the source of trehalose can be only obtained from external via transportation with trehalose PTS permease. However, sugar can be degraded with both low or high osmolarity in E.coli. Glucokinase can phosphorylate free gluocose into glucose-6-phosphate and both glucose-6-phosphate moieties enter glycolysis.

PW353415

Pw353415 View Pathway
metabolic

Trehalose Degradation I (Low Osmolarity)

Edwardsiella tarda ATCC 23685
In E.coli, trehalose can be only synthesized with high osmolarity, and if the osmolarity is low, then the source of trehalose can be only obtained from external via transportation with trehalose PTS permease. However, sugar can be degraded with both low or high osmolarity in E.coli. Glucokinase can phosphorylate free gluocose into glucose-6-phosphate and both glucose-6-phosphate moieties enter glycolysis.

PW012870

Pw012870 View Pathway
metabolic

Trehalose metabolism

Homo sapiens

PW132333

Pw132333 View Pathway
metabolic

Treosulfan Drug Metabolism

Homo sapiens
Treosulfan is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Treosulfan passes through the liver and is then excreted from the body mainly through the kidney.

PW146425

Pw146425 View Pathway
drug action

Treosulfan Drug Metabolism Action Pathway

Homo sapiens

PW128116

Pw128116 View Pathway
drug action

Treprostinil Action Pathway

Homo sapiens
Treprostinil is a stable tricyclic analogue of prostacyclin, it promotes vasodilation and inhibition of platelet aggregation. Treprostinil is administered either subcutaneously, orally or through inhalation used to treat pulmonary arterial hypertension as it acts as an anti-thrombotic agent and potent vasodilator. The drug binds and activates prostacyclin, prostaglandin D2 and P2Y purinoceptor 12 receptors that lead to activation and increased formation of cAMP levels. These elevated cAMP concentrations cause the efflux of calcium and calcium-activated potassium channels leading to cell hyperpolarization. Leading to the inhibition of platelet aggregation and vasodilation of the blood vessels. Treprostinil is metabolized by the liver by CYP2C8 and CYP2C into other metabolites that are excreted in urine.

PW144500

Pw144500 View Pathway
drug action

Treprostinil Drug Metabolism Action Pathway

Homo sapiens

PW175917

Pw175917 View Pathway
metabolic

Triacylglyceride (TG) Pathway

Homo sapiens
A triglyceride (TG, triacylglycerol, TAG, or triacylglyceride) is an ester derived from glycerol and three fatty acids. Triglycerides are the main constituents of body fat in humans and other animals, as well as vegetable fat. They are also present in the blood to enable the bidirectional transference of adipose fat and blood glucose from the liver, and are a major component of human skin oils (Wikipedia). Dihydroxyacetone phosphate (or glycerone phosphate) from glycolysis is used by the cytosolic enzyme glycerol-3-phosphate dehydrogenase [NAD(+)] to synthesize sn-glycerol 3-phosphate. Second, the mitochondrial outer membrane enzyme glycerol-3-phosphate acyltransferase esterifies an acyl-group to the sn-1 position of sn-glycerol 3-phosphate to form 1-acyl-sn-glycerol 3-phosphate (lysophosphatidic acid or LPA). The next three steps are localized to the endoplasmic reticulum membrane. The enzyme 1-acyl-sn-glycerol-3-phosphate acyltransferase converts LPA into phosphatidic acid (1,2-diacyl-sn-glycerol 3-phosphate) by esterifying an acyl-group to the sn-2 position of the glycerol backbone. Next, magnesium-dependent phosphatidate phosphatase catalyzes the conversion of phosphatidic acid into diacylglycerol. Last, the enzyme diacylglycerol O-acyltransferase synthesizes triacylglycerol from diacylglycerol and a fatty acyl-CoA.